Average Co-Inventor Count = 3.48
ph-index = 37
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Regeneron Pharmaceuticals, Inc. (190 from 1,333 patents)
2. Yale University (19 from 1,321 patents)
3. Institute for Research in Biomedicine (irb) (18 from 20 patents)
4. Other (7 from 832,448 patents)
5. University of California (3 from 15,375 patents)
6. Max-planck-gesellschaft Zur Forderung Der Wissenschaften E.v. (3 from 1,265 patents)
7. University of Texas System (2 from 5,417 patents)
8. Regeneran Pharmaceuticals, Inc. (2 from 49 patents)
9. Univ. of Texas (2 from 3 patents)
10. Duke University (1 from 2,001 patents)
11. St. Jude Children's Research Hospital (1 from 260 patents)
12. Institute for Research in Biomedicine (1 from 56 patents)
13. Columbia University (2,481 patents)
14. Regeneron Pharmacueticals, Inc. (0 patent)
199 patents:
1. 12441800 - Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof
2. 12415856 - EGFR x CD28 multispecific antibodies
3. 12402611 - Genetically modified mice and engraftment
4. 12268730 - Use of a VEGF antagonist to treat angiogenic eye disorders
5. 12251440 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
6. 12162943 - High affinity human antibodies to human IL-4 receptor
7. 12127537 - Genetically modified non-human animals and methods of use thereof
8. 12127536 - Humanized M-CSF mice
9. 12037596 - Targeted modification of rat genome
10. 11986511 - Use of a VEGF antagonist to treat angiogenic eye disorders
11. 11975045 - Use of a VEGF antagonist to treat angiogenic eye disorders
12. 11964016 - Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy
13. 11912767 - EGFR × CD28 multispecific antibodies
14. 11866503 - Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor
15. 11820997 - Methods and compositions for the targeted modification of a genome